| ATENOLOL | |||
|
PRODUCT IDENTIFICATION |
|||
| CAS NO. | 29122-68-7 |
|
|
| EINECS NO. | 249-451-7 | ||
| FORMULA | C14H22N2O3 | ||
| MOL WT. | 266.34 | ||
|
H.S. CODE |
|||
|
TOXICITY |
|||
| SYNONYMS | Anselol; Apo-atenolol; Atenolol; Noten; | ||
| 4-[2'-Hydroxy-3'-[(1- methylethyl) amino]propoxy] benzeneacetamide; Tenormin; Tenlol; | |||
| PRICE |
|
||
CLASSIFICATION |
|
||
|
PHYSICAL AND CHEMICAL PROPERTIES |
|||
| PHYSICAL STATE | White to off-white crystalline powder | ||
| MELTING POINT | 152 C | ||
| BOILING POINT | |||
| SPECIFIC GRAVITY | |||
| SOLUBILITY IN WATER | Insoluble | ||
| pH | |||
| VAPOR DENSITY |
|
||
| AUTOIGNITION |
|
||
| NFPA RATINGS | |||
|
REFRACTIVE INDEX |
|||
| FLASH POINT | |||
| STABILITY |
Stable under ordinary conditions. |
||
|
GENERAL DESCRIPTION & APPLICATIONS |
|||
|
Atenolol: a cardioselective beta1-adrenoreceptor blocking agent in the treatment of hypertension, angina pectoris, and myocardial infarction. Metoprolol tartrate, tartrate salt of metoprolol, is a white crystalline powder; sparingly soluble in water, methylene chloride, soluble in methanol, insoluble in ether; melting point 152 C; administered orally and intravenously. Chemical designation is 4-[2'-hydroxy-3'- [(1- methylethyl) amino] propoxy] benzeneacetamide. Examples of alpha-beta combined brokers are carvedilol and labetalol, alpha-Brokers; alfuzosin, doxazosin, indoramin, phenoxybenzamine, phentolamine, prazosin, tamsulosin, terazosin, thymoxamine and beta-blockers examples include atenolol, metoprolol, oxprenolol, propranolol (most of the generic names for beta blockers end with 'olol'). |
|||
| SALES SPECIFICATION | |||
|
APPEARANCE |
White to off-white crystalline powder | ||
|
IDENTIFICATION |
passes test A,B |
||
| ASSAY |
98.0.% - 101.0% |
||
|
RELATED SUBSTANCE |
Complies |
||
|
SULFATED ASH |
0.1% max |
||
|
HEAVY METALS |
10ppm max |
||
| LOSS ON DRYING |
0.5%
max
|
||
| TRANSPORTATION | |||
| PACKING |
|
||
| HAZARD CLASS | |||
| UN NO. | |||
| OTHER INFORMATION | |||
| Hazard Symbols: , Risk Phrases: , Safety Phrases: 22-24/25 | |||
| We respect the intellectual property of Yamanouchi's U.S.Patent Nos. 4,703,063, 4761,500, 4772,475 and 4,868,216, 4,987,152. We are not offering tamsulosin in the United States. | |||
